CA
AMED

CoreCap Advisors’s Amedisys AMED Stock Holding History

CoreCap Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$3.01K Buy
+36
New +$3.25K ﹤0.01% 1859
2022
Q1 		– Sell
-539
Closed -$87K – 601
2021
Q4 		$87K Buy
+539
New +$86.6K 0.01% 802

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CoreCap Advisors's AMED Position: Q4 2022 in Review

CoreCap Advisors opened a new position in Amedisys (AMED) in Q4 2022: 36 shares worth $3.01K. The stake represents ﹤0.01% of the portfolio and ranks #1859 among its holdings. This is a return to the name: CoreCap Advisors previously reported a position in AMED as recently as Q4 2021.

CoreCap Advisors first reported a position in AMED in Q4 2021 and has held it in 2 quarters since. The position peaked at $87K in Q4 2021. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

  • CoreCap Advisors held 36 shares of Amedisys worth $3.01K as of Q4 2022.
  • Amedisys was a new CoreCap Advisors position in Q4 2022.
  • Amedisys made up ﹤0.01% of CoreCap Advisors's portfolio in Q4 2022, its #1859 holding.
  • CoreCap Advisors first reported a position in Amedisys in Q4 2021 and has held it in 2 quarters since.
  • CoreCap Advisors's Amedisys position peaked at $87K in Q4 2021.
  • 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on CoreCap Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.